Category: Smith & Nephew
Johnson & Johnson subsidiary DePuy Orthopaedics plans to phase out sales of all of its metal-on-metal hip implants effective August 31, citing slowing sales and new FDA classification.
Johnson & Johnson (NYSE:JNJ) is pulling the plug on its troubled metal-on-metal hip implant business, effective August 31.
New Jersey governor Chris Christie's revelation this week that he had LAP-BAND procedure for weight loss hightlights the power of celebrity endorsements for medical procedures
When the New York Post broke the story this week that New Jersey governor and presidential hopeful Chris Christie had underwent weight loss surgery using the LAP-BAND in February some on Wall Street bemoaned the rotund politicians timing.
Physicians in Europe have been slow to adopt renal denervation technology to treat high blood pressure, Medtronic CEO Omar Ishrak says, due to low reimbursement rates and a lack of understanding of the cutting-edge procedure.
Medtronic (NYSE:MDT) CEO Omar Ishrak said low reimbursement rates and a lack of understanding of the technology have hampered the uptake of renal denervation for high blood pressure in Europe.
Smith & Nephew announced a $300 million share repurchasing program and an acquisition in India's mid-tier trauma sector, alongside sliding 1st-quarter profits and flat sales.
Under the terms of a legal settlement former Kinetic Concepts sales executive Israel Vierma is barred from involvement in Smith & Nephew's Latin American operations for nearly 2 years.
A former Kinetic Concepts Inc. executive who jumped ship for arch-rival Smith & Nephew successfully quashes his deposition in a KCI lawsuit accusing him of breach of contract.
Smith & Nephew says it plans to acquire its Brazilian distributor for an undisclosed amount.
Smith & Nephew (FTSE:SN, NYSE:SNN) is moving to a direct sales model in Brazil with the acquisition of Pró Cirurgia Especializada, its longstanding distributor in the Carioca State.